Cenobamate Open-Label Extension Study for YKP3089C025

Clinical trial NCT03961568 · COMPLETED

Trial details

NCT number: NCT03961568
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy

Start date: 2019-08-13
Primary completion: 2026-06-10
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.